Artificial intelligence is opening a new chapter in preventive eye care. iCare Screening Solution is a fully automated, AI-assisted system for the early detection of retinal diseases that threaten vision, including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma. By combining TrueColor confocal imaging, cloud-based workflows, and AI analysis, healthcare providers and optical retailers can deliver improved patient outcomes, including earlier detection and increased efficiency.
Why is iCare Screening Solution timely?
Ophthalmologists: growing workloads and efficiency challenges
Diabetic retinopathy remains a leading cause of blindness. As Professor Nina Hautala noted at the iCare Satellite Symposium during EURETINA 2025, “Only systematic screening can detect changes before vision is lost.”
With workloads increasing, ophthalmologists seek ways to improve efficiency without compromising accuracy. AI-powered screening automates image acquisition and analysis, reducing manual grading and freeing time for direct patient care.
Diabetologists: the invisible complication in daily practice
From the diabetologist’s perspective, the risk for the patient lies in how silently complications can develop without being noticed. A 73-year-old woman with type 2 diabetes came to a routine visit with no vision complaints. Combining imaging with iCare DRSplus and analyzing images with iCare RETCAD, revealed signs of severe non-proliferative retinopathy in both eyes.
“This case shows the real value of AI-powered screening: the patient had no symptoms, but urgent referral prevented vision loss,” her clinician emphasized.
Optical chains: accessibility and prevention
Optical retailers often serve customers who do not regularly visit an ophthalmologist or optometrist. For the Viehoff Gruppe, this was the starting point. “We want to be the first point of contact for healthy vision. With AI, we can provide results immediately and explain them personally—our customers don’t have to settle for just receiving a letter days later,” said Daniela Steinkämper from the management team.
Learn why early detection changes outcomes – explore more clinical cases
How does iCare Screening Solution work?
The iCare Screening Solution brings together three powerful iCare products into one seamless workflow:
- iCare DRSplus fundus camera for TrueColor confocal imaging
- iCare ILLUME cloud platform for secure image management
- iCare RETCAD AI stand-alone software for rapid analysis of DR, AMD, and glaucoma
Ophthalmologists: image quality and clinical trust
Image quality is critical for both human graders and AI. With iCare DRSplus, most images are rated excellent or good. “AI reports are available within seconds and provide clear referral recommendations. This accuracy, close to 95%, builds confidence in decision-making,” explains Professor Hautala.
Diabetologists: practical “fast track” for patients
In daily practice, the value lies in speed and clarity: non-mydriatic imaging, instant AI analysis, and clear referral guidance. For the patient described earlier, this meant immediate angiography and treatment. Instead of silent progression, the disease course was altered by early detection.
Optical chains: immediacy that builds trust
Viehoff Gruppe highlighted immediacy as a decisive factor. “Our staff feel more confident discussing results when AI provides clear grading. Customers value that nothing is left vague – they leave the store with a report and a plan,” Steinkämper describes.
See how AI performance compares to human graders in published studies
From pilot to practice
Adopting new technology into a daily healthcare routine requires more than just technical performance and integration—it also necessitates training and a focus on user and patient experience. The following insights from clinics and optical retailers reveal how they have successfully implemented iCare screening solution and achieved long-term outcomes.
Ophthalmologist: integration, compliance, and training
Clinical adoption requires smooth integration into existing workflows. “For successful use, algorithms must be validated in real-world settings, and staff must be trained to interpret AI results effectively,” Professor Hautala points out.
Diabetologists: automation and patient flow
Automated operation and no-dilation approach reduce training needs and improve patient throughput. Increased screening coverage, more efficient referrals contribute to improved long-term outcomes.
Optical chains: phased roll-out and customer experience
Viehoff Gruppe rolled out screening in phases. Two stores initially piloted the solution, followed by four more, before the solution was scaled further. Staff training was crucial: “We trained several employees per store as experts, so colleagues always have someone to turn to when explaining AI reports,” Steinkämper explained.
Discover the full implementation story and lessons learned
Moving forward – earlier detection, better outcomes
Experiences from ophthalmologists, diabetologists, and optical chains show that iCare screening solution delivers real benefits across care pathways. It empowers clinicians with accurate AI reports, provides diabetologists with a tool to protect patients from vision loss, and enables optical chains to expand their role in preventive eye health.
Earlier detection enables better outcomes. With AI-powered analysis, TrueColor imaging, and cloud-based workflows, iCare Screening Solution is redefining how eye care is delivered.
Ready to dive deeper?
Discover how iCare Screening Solution improves patient care with AI-powered screening.
Explore the full iCare screening solution overview
